PTC Re-iterates Full Year 2019 Guidance: PTC anticipates full year DMD franchise net product revenues to be between $285 and $305 million. PTC anticipates GAAP R&D and SG&A expense for the full year 2019 to be between $395 and $405 million. PTC anticipates Non-GAAP R&D ...
The disclosure relates to polypeptides, vaccines and pharmaceutical compositions that find use in the prevention or treatment of Coronaviridae or SARS-CoV-2 infection. The disclosure also relates to methods of treating or preventing Coronaviridae or SARS-CoV-2 infection in an individual. The polypepti...
("Scout"), Explorer and Scout will combine their respective pharmacy businesses and Scout will be merged with and into Explorer (the "Merger") and Explorer shall be the surviving corporation (capitalized terms used herein and not otherwise defined shall have the meaning set forth in the Merger ...